期刊论文详细信息
BMC Complementary and Alternative Medicine
Classification of ginseng berry (Panax ginseng C.A. MEYER) extract using 1H NMR spectroscopy and its inhibition of lipid accumulation in 3 T3-L1 cells
Young Ock Kim2  Mariadhas Valan Arasu6  Hyung-Kyoon Choi4  Sae Won Na1  Kee Hong Kim2  Young Chang Kim2  Hyung Don Kim2  Sang Won Lee2  Eun Suk Sohn5  Hae Ran Park2  Seung Ok Yang3 
[1] College of Veterinary Medicine, ChonBuk National University, Jeonju-si, South Korea;Department of Medicinal Crop Research NIHHS RDA Eumsung, Chungbuk 369-873, Republic of Korea;Dapartment of food science and engineering, Ewha Womans University, 11-1 Daehyun-dong, Seodaemun-gu, Seoul 120-750, Republic of Korea;College of pharmacy, Chung-Ang University, Seoul 156-756, Republic of Korea;Department of Applied Biochemistry, College of Biomedical & Health Science, Konkuk University, Chungju 380-701, South Korea;Department of Botany and Microbiology, Addiriyah Chair for Environmental Studies, College of Science, King Saud University, P. O. Box 2455, Riyadh 11451, Saudi Arabia
关键词: Maturation;    Metabolite profiling;    Obesity;    Panax ginseng berry;   
Others  :  1085330
DOI  :  10.1186/1472-6882-14-455
 received in 2014-08-25, accepted in 2014-11-13,  发布年份 2014
PDF
【 摘 要 】

Background

Panax ginseng is a famous traditional medicine in Korea for its beneficial effect on obesity, cardiac and liver associated diseases. The aim of this study was to investigate the metabolite in Panax ginseng (P. ginseng, Aralicaceae) berries depending on the ripen stages and evaluate its potential inhibition on adipocyte differentiation in 3 T3-L1 cells.

Methods

Different ripening stage samples of P. ginseng berry were analyzed through global metabolite profiling by NMR spectroscopy. Lipid accumulation in the cells was analyzed by Oil Red O staining.

Results

The PLS-DA clearly distinguished P. ginseng berry extract (PGBE) according to the partial ripe (PR), ripe(R) and fully ripe (FR) stage. Lipid accumulation of PGBE was examined by measuring triglyceride content and Oil-Red O staining. These results suggested that the FR stage of PGBE decrease in lipid accumulation during adipocyte differentiation and the amount of threonine, asparagine, fumarate, tyraine, tyrosine, and phenylalanine increased with longer ripening of ginseng berries.

Conclusion

Metabolite profiling of P. ginseng was identified by 1H NMR spectra. P. ginseng extract efficiently inhibits adipogenesis in 3 T3-L1 adipocytes concluded that the P. ginseng has the antiobesity properties.

【 授权许可】

   
2014 Yang et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150113172416309.pdf 1968KB PDF download
Figure 3. 109KB Image download
Figure 2. 92KB Image download
Figure 1. 63KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】
  • [1]Leonhardt M, Hrupka B, Langhans W: New approaches in the pharmacological treatment of obesity. Eur J Nutr 1999, 38:1-13.
  • [2]Monteiro R, Azevedo I: Chronic inflammation in obesity and the metabolic syndrome. Medi Infla 2010, 2010:1-10.
  • [3]Zalilah MS, Khor GL, Mirnalini K, Norimah AK, Ang M: Dietary intake, physical activity and energy expenditure of Malaysian adolescents. Sin Med J 2006, 47:491.498.
  • [4]Block KI, Mead MN: Immune system effects of echinacea, ginseng, and astragalus: A review. Int Can Ther 2003, 2:247-267.
  • [5]Nah SY, Kim DH, Rhim H: Ginsenosides: Are any of them candidates for drugs acting on the central nervous system? CNS Drug Rev 2007, 13:381-404.
  • [6]Xie JT, Mchendale S, Yuan CS: Ginseng and diabetes. Am J Chin Med 2005, 33:397-404.
  • [7]Yun TK: Experimental and epidemiologic evidence on non-organ specific cancer preventive effect of Korean red ginseng and identification of active compounds. Mut Res 2003, 523–524:63-74.
  • [8]Kim S, Kim T, Ahn K, Park WK, Nah SY, Rhim H: Ginsenoside Rg3 antagonizes NMDA receptors through a glycine modulatory site in rat cultured hippocampal neurons. Biochem Biophy Res Comm 2004, 323:416-424.
  • [9]Lee Florence C: Facts About Ginseng: The Elixir of Life. In Elizabeth, NJ, USA: Hollym International Corporation; 1992.
  • [10]Kim YK, Yoo DS, Xu H, Park NI, Kim HH, Choi JE, Park SU: Ginsenoside content of berries and roots of three typical Korean ginseng (Panax ginseng) cultivars. Nat Pro Comm 2009, 4:903-906.
  • [11]Quan HY, Yuan HD, Jung MS, Ko SK, Park YG, Chung SH: Ginsenoside Re lowers blood glucose and lipid levels via activation of AMP-activated protein kinase in HepG2 cells and high-fat diet fed mice. Int J Mol Med 2012, 29:73-80.
  • [12]Yang SY, Kim HK, Lefeber AWM, Erkelens C, Angelova N, Choi YH, Verpoorte R: Application of two dimensional nuclear magnetic resonance spectroscopy to quality control of ginseng commercial products. Planta Med 2006, 72:364-369.
  • [13]Lee EJ, Shaykhutdinov R, Weljie AM, Vogel HJ, Facchini PJ, Park SU, Kim YK, Yang TJ: Quality assessment of ginseng by 1H NMR metabolite fingerprinting and profiling analysis. J Agri Food Chem 2009, 57:7513-7522.
  • [14]Green H, Kehinde O: An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 1975, 5:19-27.
  • [15]Atanasov AG, Wang JN, Gu SP, Bu J, Kramer MP, Baumgartner L, Fakhrudin N, Ladurner A, Malainer C, Vuorinen A, Noha SM, Schwaiger S, Rollinger JM, Schuster D, Stuppner H, Dirsch VM, Heiss EH: Honokiol: A non-adipogenic PPARγ agonist from nature. Biochim Biophys Acta 1830, 2013:4813-4819.
  • [16]Datau EA, Wardhana Surachmanto EE, Pandelaki K, Langi JAF: Efficacy of Nigella sativa on serum free testosterone and metabolic disturbances in central obese male. Acta Med Indones 2010, 42:130-134.
  • [17]Basu A, Du M, Sanchez K, Leyva MJ, Betts NM, Blevins S, Wu M, Aston CE, Lyons TJ: Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutr 2011, 27:206-213.
  • [18]Gurrola-Díaz CM, García-López PM, Sánchez-Enríquez S, Troyo-Sanromán R, Andrade-González I, Gómez-Leyva JF: Effects of Hibiscus sabdariffa extract powder and preventive treatment [diet] on the lipid profiles of patients with metabolic syndrome [MeSy]. Phytomed 2010, 17:500-505.
  • [19]Pal S, Khossousi A, Binns C, Dhaliwal S, Ellis V: The effect of a fibre supplement compared to a healthy diet on body composition, lipids, glucose, insulin and other metabolic syndrome risk factors in overweight and obese individuals. Bri J Nutr 2011, 105:90-100.
  • [20]Amagase H, Nance DM: Lycium barbarum increases caloric expenditure and decreases waist circumference in healthy overweight men and women: pilot study. J Am Coll Nutr 2011, 30:304-309.
  • [21]Dey L, Zhang L, Yuan CS: Letter to the editor: anti-diabetic and anti-obese effects of ginseng berry extract: comparison between intraperitoneal and oral administrations. Am J Chin Med 2002, 30:645-647.
  • [22]Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, Pugh W, Rue PA, Polonsky KS, Yuan CS: Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002, 51:1851-1858.
  • [23]Kim MJ, Yang HJ, Kim JH, Ahn CW, Lee JH, Kim KS, Kwon DY: Obesity-related metabolomic analysis of human subjects in black soybean peptide intervention study by ultraperformance liquid chromatography and quadrupole-time-of-flight mass spectrometry. J Obesity 2013, 2013:1-11.
  • [24]Kim YS, Lee YM, Kim H, Kim J, Jang DK, Kim JH, Kim JS: Anti-obesity effect of morus bombycis root extract: anti-lipase activity and lipolytic effect. J Ethnopharmacol 2010, 130:621-624.
  • [25]Yun JW: Possible anti-obesity therapeutics from nature-a review. Phytochem 2010, 71:1625-1641.
  文献评价指标  
  下载次数:43次 浏览次数:12次